Dr. Marilyn Huestis retires
This week the National Institute on Drug Abuse (NIDA) announced that Dr. Marilyn Huestis, Chief of Chemistry and Drug Metabolism at NIDA’s Intramural Research Program (IRP) in Baltimore, Maryland, has...
View ArticleNaloxone prescriptions from pharmacies increased ten-fold
A new scientific analysis shows prescriptions for naloxone, a medication designed to rapidly reverse opioid overdose, has increased ten-fold in the past eighteen months. Naloxone is traditionally...
View ArticleA child’s first eight years critical for substance abuse prevention
An online guide about interventions in early childhood that can help prevent drug use and other unhealthy behaviors was launched today by the National Institute on Drug Abuse (NIDA), part of the...
View ArticleNIDA and ARC announce funding opportunity for research projects to address...
The National Institute on Drug Abuse (NIDA), in partnership with the Appalachian Regional Commission (ARC), has announced a NIDA funding opportunity for one-year, services planning research grants to...
View ArticleNIH convenes Marijuana and Cannabinoids: A Neuroscience Research Summit
What: NIH to host Marijuana and Cannabinoids: A Neuroscience Research Summit, focusing on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system....
View ArticleSubstance use disorders extremely common among previously incarcerated youth
©iStock/AlexRaths New research funded by the National Institute on Drug Abuse revealed that of previously incarcerated youths, more than 90% of males and nearly 80% of females had a substance use...
View ArticleReview article outlines strategies to reduce opioid abuse risk
©Shutterstock/David Smart More than 30 percent of Americans have some form of chronic pain. Yet, the over-reliance on the millions of opioid pain reliever prescriptions dispensed yearly have resulted...
View ArticleBrain dopamine release reduced in severe marijuana dependence
©istockphoto/wenht NIDA-funded research using brain scans shows that severe marijuana dependence (now referred to as cannabis use disorder) is associated with a reduced release of dopamine within the...
View ArticleExtended-release naltrexone lowers relapse rates in ex-offenders
©istockphoto/kwanchaichaiudom New research funded by the National Institute on Drug Abuse (NIDA) revealed that the initial relapse rates among opioid-dependent adults in the criminal justice system was...
View ArticleDr. Nora Volkow to Speak at X-STEM: Extreme STEM Symposium
Dr. Nora Volkow, director of the National Institute on Drug Abuse, part of the National Institutes of Health, will speak about the addicted brain at X-STEM, an Extreme STEM Symposium for middle through...
View ArticleExpanded National Drug and Alcohol Facts Week begins January 25
An annual, week-long observance that brings together teens and scientific experts to shatter persistent myths about substance use and addiction will feature information about alcohol in addition to...
View ArticleTranslational research focus of NIDA organizational shift
The National Institute on Drug Abuse (NIDA) has reorganized its divisional structure to integrate its research portfolio, promote translational research and increase efficiencies. The new structure...
View ArticleNIH launches landmark study on substance use and adolescent brain development
The National Institutes of Health today awarded 13 grants to research institutions around the country as part of a landmark study about the effects of adolescent substance use on the developing brain....
View ArticleNIDA redesigns Easy to Read and Learn the Link websites for mobile devices
The National Institute on Drug Abuse (NIDA) has redesigned two of its websites, Easy to Read and Learn the Link, for use on mobile devices. This new responsive design model automatically adjusts each...
View ArticleCollege and young adult drug use data now available online
Also new: list of college programs in addiction studies The National Institute on Drug Abuse (NIDA) is pleased to announce that the latest Monitoring the Future (MTF) national survey results for...
View ArticleReducing nicotine in cigarettes decreases use, dependence and cravings
New NIDA-funded research shows that cutting the amount of nicotine in cigarettes leads to a reduction in the amount of cigarettes smoked per day, decreased nicotine dependence, and reduced cravings....
View ArticleNIDA-NIAAA Mini-Convention: Frontiers in Addiction Research
Society for Neuroscience satellite meeting explores innovative brain science, including the brain structure-function relationships in human development, developmental consequences of drug and alcohol...
View ArticleNIDA announces new awards for the Clinical Trials Network
The National Institute on Drug Abuse (NIDA) is pleased to announce the award of 13 grants to fund the continuation of the National Drug Abuse Treatment Clinical Trials Network (CTN). The CTN provides...
View ArticleNIDA Issues Challenge to Create App for Addiction Research
App will use Apple’s ResearchKit™ Framework The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today issued a Challenge “Addiction Research: There’s an App for...
View ArticleFDA approves naloxone nasal spray to reverse opioid overdose
Image courtesy of ADAPT Pharma, Inc. Easy-to-use technology provides alternative to injectable form of lifesaving medication The National Institute on Drug Abuse (NIDA), part of the National Institutes...
View Article